Biogen (BIIB) FCF Margin (2009 - 2026)
Biogen (BIIB) recorded FCF Margin of 21.41% in Q3 2026, down 26.97 percentage points from 48.38% a year earlier but up 6.50 percentage points from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) FCF Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Biogen's FCF Margin came in at 20.11% as of Sep 30, 2026, down 2.78 percentage points year-over-year; for FY2025, it was 20.73%, down 7.39 percentage points from FY2024.
- Annual FCF Margin has a five-year change of -7.57 percentage points (FY2020 to FY2025).
- Across earlier years, FCF Margin came in at 28.13% in FY2024 (+15.22 pp), 12.91% in FY2023 (+1.67 pp), 11.25% in FY2022 (-19.55 pp) and 30.79% in FY2021 (+2.49 pp).
- Quarterly FCF Margin has ranged from -10.28% in Q4 2022 to 48.38% in Q3 2025 over the past five years.
- On a year-over-year basis, FCF Margin rose in four of the last eight quarters, with an average year-over-year change of +0.04 percentage points.
- Peak year-over-year performance for FCF Margin in the last five years was a gain of 44.66 percentage points in Q4 2021, against a drop of 39.05 percentage points in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 14.91% (Q2 2026), 23.98% (Q1 2026) and 20.53% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 28.96% |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn | 21.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 21.41% |
| Jun 30, 2026 | 14.91% |
| Mar 31, 2026 | 23.98% |
| Dec 31, 2025 | 20.53% |
| Sep 30, 2025 | 48.38% |
| Jun 30, 2025 | 5.08% |
| Mar 31, 2025 | 9.14% |
| Dec 31, 2024 | 29.40% |
| Sep 30, 2024 | 36.52% |
| Jun 30, 2024 | 24.03% |
| Mar 31, 2024 | 22.15% |
| Dec 31, 2023 | -2.21% |
| Sep 30, 2023 | 20.48% |
| Jun 30, 2023 | 16.94% |
| Mar 31, 2023 | 15.78% |
| Dec 31, 2022 | -10.28% |
| Sep 30, 2022 | 23.99% |
| Jun 30, 2022 | 27.02% |
| Mar 31, 2022 | 4.10% |
| Dec 31, 2021 | 28.78% |
API Access
Biogen FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();